Abstract
Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML (N Engl J Med 2019;381:1728-1740). The article contained errors in the number......
小提示:本篇文献需要登录阅读全文,点击跳转登录